Cardiac Stress Test - Pharmacological Agents

Pharmacological Agents

The choice of pharmacologic stress agents used in the test depends on factors such as potential drug interactions with other treatments and concomitant diseases.

Pharmacologic agents such as Adenosine, Lexiscan (Regadenoson), or dipyridamole is generally used when a patient cannot achieve adequate work level with treadmill exercise, or has poorly controlled hypertension or left bundle branch block. However, a exercise stress test may provide more information about exercise tolerance than a pharmacologic stress test.

Commonly used agents include:

  • Vasodilators acting as adenosine receptor agonists, such as Adenosine itself, and Dipyridamole (brand name "Persantine"), which acts indirectly at the receptor.
  • Regadenoson (brand name "Lexiscan"), which acts specifically at the Adenosine A2A receptor, thus affecting the heart more than the lung.
  • Dobutamine. The effects of beta-agonists such as dobutamine can be reversed by administering beta-blockers such as propranolol.

Lexiscan (Regadenoson) or Dobutamine is often used in patients with severe reactive airway disease (Asthma or COPD) as adenosine and dipyridamole can cause acute exacerbation of these conditions. If the patient's Asthma is treated with an inhaler then it should be used as a pre-treatment prior to the injection of the pharmacologic stress agent. In addition, if the patient is actively wheezing then the physician should determine the benefits versus the risk to the patient of performing a stress test especially outside of a hospital setting.

Aminophylline may be used to attenuate severe and/or persistent adverse reactions to Adenosine and Lexiscan.

Read more about this topic:  Cardiac Stress Test

Famous quotes containing the word agents:

    The Times are the masquerade of the eternities; trivial to the dull, tokens of noble and majestic agents to the wise; the receptacle in which the Past leaves its history; the quarry out of which the genius of today is building up the Future.
    Ralph Waldo Emerson (1803–1882)